Pancreatic Cancer Research

ResearcherKagawa UniversityActive in the last 2 years

Takashi Norikane

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0989-8369; OpenAlex author ID A5037777885. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Predicting pathological response to neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic ductal adenocarcinoma: a comparative study… Co-author DOI 10.1186/s13550-025-01342-3↗
  2. Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.17151↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keiichi Okano · 2 shared papers, 2024–2025 · strength 0.42
  2. Y Nishiyama · 1 shared paper, 2025 · strength 0.24
  3. Ayaka Shimomura · 1 shared paper, 2024 · strength 0.18
  4. Hironobu Suto · 1 shared paper, 2024 · strength 0.18
  5. Minoru Oshima · 1 shared paper, 2024 · strength 0.18
  6. Mina Nagao · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.